Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.
by GMFH Editing Team
Significant strides have been made in our comprehension of the role of the gut microbiome in health and disease throughout the year 2022. We invite you to take a closer look at the "2022 Year at a Glance" report and learn about the groundbreaking discoveries made.
by GMFH Editing Team
The Human Microbiome Action project is inviting experts in microbiome-based biomarker development to participate in a Delphi survey.
by Andreu Prados
While fecal microbiota transplants are recommended for multiple recurrent Clostridioides difficile infection, their use in clinical practice is hindered by a lack of regulation and understanding of the underlying ecological dynamics. This article covers major challenges for the treatment in transitioning from bench to bedside, from the scientific, clinical and regulatory perspectives (Part 6).
by GMFH Editing Team
It has been 10 years since GMFH was launched with the aim of disseminating the latest gut microbiome research to the lay public, healthcare professionals and scientists alike. In this article, members of the GMFH board of experts share their pick of the most significant advances in the field, outlining their clinical impact and implications for further research.
by Andreu Prados
Gut fungi found in the lower gastrointestinal tract can influence the host immune system just like the bacterial microbiota. This article focuses on the role of the gut mycobiota in immune system homeostasis and its relevance for host health.
by Andreu Prados
A wide range of diseases, from irritable bowel syndrome to depression, have been associated with increased intestinal permeability or ‘leaky gut’. What does a leaky gut mean, how can it be diagnosed and what available dietary strategies work for managing it?
by GMFH Editing Team
The 11th Gut Microbiota for Health World Summit will take place on March 11 and 12 2023 in Prague, Czech Republic. This edition has an excellent scientific program in store for you, which focuses on the next generation of microbiota-based therapy and nutrition.
by Andreu Prados
Clostridioides difficile infection is a common cause of diarrhea in both the hospital and community settings, with C. difficile recurrence one of the most challenging outcomes to address. This article focuses on the factors that predict long-term complications of C. difficile infection and what can be done in clinical practice to minimize them (Part 5).
by Konstantina Zafeiropoulou
Just one month before friends and families gather around the Christmas table, November is here to bring awareness around Clostridioides difficile infection, and the importance of microbiota-derived treatments. With this post, all of us in GMFH aim to highlight the importance of protecting ourselves and families and stopping the spread of this potentially deadly infection.
Research into microbial extracellular vesicles has progressed significantly over several decades. Following up on the 1989 breakthrough that bacterial extracellular vesicles contain genetic information, and the recent ISAPP definition on postbiotics, current research suggests bacterial extracellular vesicles derived from probiotic bacteria may be the postbiotics of the future with potential health benefits.
